Effects of hyperuricemia on renal function of renal transplant recipients: A systematic review and Meta-analysis of cohort studies

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Huang, Yan ^a   Li, Yu Lin ^b   Huang, He ^a   Wang, Ling ^c   Yuan, Wen Ming ^d   Li, Jing ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Department of Cardiology   (China)

^d THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; URIC ACID;

ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERURICEMIA; KIDNEY ALLOGRAFT; ONSET AGE; OUTCOMES RESEARCH; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL;

COHORT STUDIES; HUMANS; HYPERURICEMIA; KIDNEY; KIDNEY TRANSPLANTATION;

EID: 84862649931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039457     Document Type: Article

References (32)

1. Hashmi S, Poommipanit N, Kahwaji J, Bunnapradist S, (2007) Overview of renal transplantation. Minerva Medica 98: 713-729.
2. Karthikeyan V, Karpinski J, Nair RC, Knoll G, (2004) The Burden of Chronic Kidney Disease in Renal Transplant Recipients. American Journal of Transplantation 4: 262-269.
3. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, et al. (2005) Status of Endothelial Dependent Vasodilation in Patients With Hyperuricemia. The American Journal of Cardiology 96: 1576-1578.
4. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, et al. (2005) Hyperuricemia induces endothelial dysfunction. Kidney International 67: 1739-1742.
5. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, et al. (2008) Inactivation of nitric oxide by uric acid. Nucleosides, Nucleotides & Nucleic Acids 27: 967-978.
6. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, et al. (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41: 1287-1293.
7. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, et al. (2005) Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. American Journal of Nephrology 25: 425-433.
8. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, et al. (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. American Journal of Physiology- Renal Physiology 282: F991-F997.
9. Kang DH, Park SK, Lee IK, Johnson RJ, (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. Journal of the American Society of Nephrology 16: 3553-3562.
10. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, et al. (2006) Uric acid and inflammatory markers. European Heart Journal 27: 1174-1181.
11. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes care 32: 1737-1742.
12. Mazzali M, (2005) Uric acid and transplantation. [Review] [66 refs]. Seminars in Nephrology 25: 50-55.
13. Yu-lin L, Ling W, Jing L, Yan H, Wen-ming Y, (2011) The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies. CHINESE JOURNAL OF INTERNAL MEDICINE 50: 555-561.
14. Siu YP, Leung KT, Tong MK, Kwan TH, (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. American Journal of Kidney Diseases 47: 51-59.
15. Chung BH, Kang SH, Hwang HS, Choi BS, Park CW, et al. (2011) Clinical significance of early-onset hyperuricemia in renal transplant recipients. Nephron- Clinical Practice 117: c276-c283.
16. Gerhardt U, Huttmann MG, Hohage H, (1999) Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clinical Transplantation 13: 375-379.
17. Zou GM, Sui WG, Yan Q, Che WT, Chen HZ, et al. (2010) Influence of hyperuricemia on long-term renal allograft function after renal transplantation* is it a factor of chronic renal allograft dysfunction? Journal of Clinical Rehabilitative Tissue Engineering Research 14: 923-927.
18. Abdelrahman M, Rafi A, Ghacha R, Youmbissi JT, Qayyum T, et al. (2002) Hyperuricemia and gout in renal transplant recipients. Renal Failure 24: 361-367.
19. Akalin E, Ganeshan SV, Winston J, Muntner P, (2008) Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Transplantation 86: 652-658.
20. Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, et al. (2007) Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplantation Proceedings 39: 1023-1026.
21. Bandukwala F, Huang M, Zaltzman JS, Nash MM, Prasad GVR, (2009) Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. American Journal of Cardiology 103: 867-871.
22. Haririan A, Noguiera JM, Zandi-Nejad K, Aiyer R, Hurley H, et al. (2010) The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation 89: 573-579.
23. Karbowska A, Boratynska M, Kusztal M, Klinger M, (2009) Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Transplantation Proceedings 41: 3052-3055.
24. Min SI, Yun IJ, Kang JM, Park YJ, Min SK, et al. (2009) Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Nephrology Dialysis Transplantation 24: 2584-2590.
25. Kim KM, Kim SS, Han DJ, Yang WS, Park JS, et al. (2010) Hyperuricemia in kidney transplant recipients with intact graft function. Transplantation Proceedings 42: 3562-3567.
26. Haririan A, Metireddy M, Cangro C, Nogueira JM, Rasetto F, et al. (2011) Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis. American Journal of Transplantation 11: 1943-1950.
27. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, et al. (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. Journal of Hypertension 26: 269-275 210.1097/HJH.1090b1013e3282f1240bf.
28. Feig DI, Kang DH, Johnson RJ, (2008) Medical progress: Uric acid and cardiovascular risk. New England Journal of Medicine 359: 1811-1821.
29. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, et al. (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clinical Journal of The American Society of Nephrology: CJASN 5: 1388-1393.
30. Flury W, Ruch HR, Montandon A, (1977) [The treatment of hyperuricemia after kidney transplantation]. [German]. Schweizerische Medizinische Wochenschrift: Journal Suisse de Medecine.
31. Navascues RA, Gomez E, Rodriguez M, Laures AS, Baltar J, et al. (2002) Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients. Nephron 91: 173-174.
32. Meier-Kriesche H-U, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H, (2009) Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clinical Journal of The American Society of Nephrology: CJASN 4: 1655-1660.